Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial.
about
Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directionsCost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder.Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.Extended-release naltrexone opioid treatment at jail reentry (XOR)Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX).Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system.Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients.Therapies in early development for the treatment of opiate addiction.A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release.Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine.Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England.Initiation of extended release naltrexone (XR-NTX) for opioid use disorder prior to release from prison.Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment.Extended-release injectable naltrexone for opioid use disorder: A systematic review.A qualitative assessment of attitudes about and preferences for extended-release naltrexone, a new pharmacotherapy to treat opioid use disorders in Ukraine.
P2860
Q26746195-B72BA7D9-C09C-4B1D-A242-C326BF29B22CQ30253083-AD5E9F86-FD8E-4D34-9F3B-9FBDB43BEDB5Q30277067-D4DA33A9-9602-410E-9372-6C1D64B12513Q33755501-13F658A9-21C1-40F3-9B71-786A3CDED381Q36001217-93AB7832-1B74-4328-80AB-8EADCDB35B05Q36362007-63C4D982-E348-4ABE-B953-7F22D9BD5C2AQ36619578-C0103ABE-F0B1-4C60-880E-B13BC9C2FC98Q38594606-F903241E-7B22-4553-B017-F503DA4494BDQ39009581-C0721A23-DF65-4652-9549-F890F8EA775FQ40083753-7719D889-71EA-42E6-9BEB-1376DC9F1840Q44343100-06BA37C9-BA9C-4B52-8BC3-852967B19AE1Q44345782-F512F990-59E2-4D10-9C84-964E5F5A21AFQ44351156-D80CB1A3-4E17-478C-B3BA-6138BDE5C7C7Q47909566-B0B71D2F-DF15-413F-A7A1-672EE3FD52CFQ48111086-9626A4F4-49CE-4CB1-A337-60215B1E1913Q50130640-FCEE88F9-C043-486A-AAB7-208F5CEE65DE
P2860
Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Opioid treatment at release fr ...... andomized effectiveness trial.
@en
type
label
Opioid treatment at release fr ...... andomized effectiveness trial.
@en
prefLabel
Opioid treatment at release fr ...... andomized effectiveness trial.
@en
P2093
P2860
P50
P356
P1433
P1476
Opioid treatment at release fr ...... andomized effectiveness trial.
@en
P2093
Ellie Grossman
John Rotrosen
Ryan McDonald
P2860
P304
P356
10.1111/ADD.12894
P407
P577
2015-04-05T00:00:00Z